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1. Introduction 
Cortisol can be metabolised by reduction of the 
A ring, reduction of the 20-ketone function or by 
6/3-hydroxylation to 6&hydroxycortisol [ 1,2] . The 
latter process may be stimulated by agents such as 
drugs, pesticides or polycyclic hydrocarbons which 
induce the hydroxylating enzymes of the hepatic 
microsomes [3]. Therefore the measurement of 6/3- 
hydroxycortisol in urine may provide an index of 
enzyme induction in the liver microsomes. Further- 
more, measurement of this steroid may be useful in 
the diagnosis of Cushing’s syndrome, in which the 
increase in the production of 6/3-hydroxycortisol is 
disproportionately large relative to that of cortisol 
[4]. To date, large scale investigations of the effect 
of various agents on the urinary content of this steroid 
have been restricted by the complexity of the methods 
of measurement. Assays developed previously have 
employed either a long and tedious work-up prior to 
a non-specific colour reaction [4] or oxidation of the 
sample prior to gas-liquid chromatography [5] . 
We therefore decided to develop a specific radio- 
immunoassay for this steroid. In this communication 
we report the synthesis of a protein conjugate of 6p- 
hydroxycortisol and the characterisation of antisera 
raised against it. 
2. Materials and methods 
2.1. Reagents 
Tritiated 6/3-hydroxycortisol (sp. act. 35 Ci/mmol) 
was obtained from the Radiochemical Centre, 
Amersham, UK. Samples of 6&hydroxycortisol, 
6@hydroxycortisone, 3a, 110, 17a, 21-tetrahydroxy- 
North-Holland Publishing Company - Amsterdam 
S/3-pregnan-20-one and 110, 17a, 20~, 2 1 -tetrahydroxy- 
pregn-4-en-3-one were gifts from the MRC Reference 
Collection. All other steroids were purchased from 
Steraloids Inc., Wilton, USA. Scintillant (NE 260) was 
obtained from Nuclear Enterprises, Edinburgh and all 
samples were counted in 4 ml of this material. General 
reagents were purchased from BDH, Poole, UK and all 
solvents were redistilled prior to use. 
2.2. Synthesis of Antigen 
To a well stirred suspension of powdered cortisol 
21 -acetate (1.8 g) in anhydrous tetrahydrofuran (20 ml) 
containing absolute ethanol (2 ml) and triethylortho- 
formate (3 ml) was added 4-methylphenylsulphonic 
acid (0.04 g). After 50 min the reaction was quenched 
with pyridine (1 ml) and then poured onto ethyl 
acetate (200 ml) and saturated aqueous sodium 
bicarbonate (100 ml). The organic phase was separated, 
dried (Naz S04) and concentrated to give 2 1 -acetoxy- 
11/3,17a-dihydroxy-3-methoxypregna-3,5-dien-20-one 
as a pale yellow oil which, ‘without further purification, 
was dissolved iri ethanol (100 ml) and shaken in direct 
sunlight for 5 h. Removal of the solvent left a glass 
which, on trituration with ethyl acetate left a crystal- 
line mass which was recrystallised five times from 
acetone to give 6/3-hydroxycortisol21-acetate as 
white needles (0.62 g) which had a m.p. 216-220°C 
(lit. m.p. 219-221°C [6]). Removal of the acetate 
in methanolic sodium methoxide [6] gave 6P-hydroxy- 
cortisol which was identical with an authentic speci- 
men. 
The residue from the recrystallisation of the 
crystalline mass was separated by preparative thin 
layer chromatography on silica plates, developed in 
ethyl acetate-cyclohexane-methanol70:30:4 to 
give 6cu-hydroxycortisol2 1 -acetate (0.08 g) which, 
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after treatment with methanolic sodium methoxide, 
gave 6o-hydroxycortisol as white plates m.p. 
216-219°C (lit. m.p. 216-217°C [6]). 
A solution of 6@hydroxycortisol21-acetate (0.21 g) 
and carboxymethoxylamine hemihydrochloride 
(0.058 g) in pyridine (5 ml) was stirred at 5°C for 
24 h. Removal of the solvent in vacua left a gum 
which was taken up in ethyl acetate (50 ml), washed 
with saturated brine (10 ml X 2) dried (Na$O& 
concentrated and recrystallised from methanol- 
water to give 6P-hydroxycortisol21-acetate 3(U-car- 
boxymethyl)oxime (0.16 g) as white plates m.p. 
220-223°C. 
V,, (Nujol); 3500 (broad; hydroxyls), 1738 (ace- 
tate), 1720 (20-ketone) and 1708 cm-’ (carboxyl). 
S (de-DMSO); 0.78 (3 H, s, l%CHs), 1.38 (3 H, d, 
19-CHs), 2.06. 
(3 H, s, al-acetate), 4.07 (1 H, m, 6&-H), 4.19 (1 H, 
m, 1 la-H), 4.45. 
(2 H, d, 0.CH2 .CO), 4.90 (2 H, AB system, 20-CHz) 
and 5.70 and 6.34 (1 H, d, 4-H). 
The splitting of the peaks for 19-CHs , 0.CH2 .CO 
and 4-H protons are similar to those observed in the 
n.m.r. spectrum of cortisol3(0carboxymethyl)oxime 
[7] and show that the compound is a 2: 5 mixture of 
syn and anti isomers. The chemical shift and splitting 
pattern of the peak for the 6cY-proton are identical to 
those observed, for the corresponding proton, in the 
n.m.r. spectrum of 6/%hydroxycortisol 21-acetate. 
Mass spectrum; M’S493 (Czs Hs5 N O9 requires 
493). 
The derivatised steroid was coupled to bovine 
serum albumin (BSA) using the mixed anhydride 
technique [8] and the molar steroid: protein ratio of 
the conjugate was determined by ultraviolet spectros- 
copy to be 32. 
2.3. Immunisation and characterisation of antisera 
Antisera were raised and characterised as described 
previously [8] . 
Table 1 
Specificity and working dilutions of anti-6@hydroxycortisol-3-BSA antisera 
Steroid Antiserum 
RlB2 R2B2 R3B2 R4B2 
6@Hydroxycortisol 100 100 100 100 
6or-Hydroxycortisol 1.9 3.7 5.7 
Cortisol 1.4 58.1 1.6 3.6 
Cortisone < 0.05 < 0.05 0.05 
6p-Hydroxycortisone < 0.05 0.13 72 
6p-Hydroxycortisol 21-acetate 9.0 0.56 3.3 3.0 
3o, 110, 17q 21-tetrahydroxy < 0.05 < 0.05 < 0.05 
-5p-pregnan-20-one 
1 lp, 1701, 2001, 21-tetrahydroxypregn- < 0.05 < 0.05 < 0.05 
4-en-3-one 
Corticosterone 0.09 0.18 0.10 
1 I-Desoxycortisol < 0.05 0.08 0.02 
21-Desoxycortisol 0.05 < 0.05 0.10 
21-Hydroxyprogesterone < 0.05 < 0.05 < 0.05 
Progesterone < 0.05 < 0.05 < 0.05 
Cholesterol < 0.05 < 0.05 < 0.05 
Oestradiol < 0.05 < 0.05 < 0.05 
Testosterone < 0.05 < 0.05 < 0.05 
Working dilution (Reciprocal) 2500 1000 350 550 
Coding of antisera: Rl-R4 refers to four individual rabbits and B2 refers to blood 
samples removed after the third booster injection. 
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3. Results 
The working dilutions of the blood samples 
removed from the four rabbits following the second 
booster injections were as follows: Rl Bl 120: 1, 
R2Bl < lOO:l, R3Bl lOO:l, and R4Bl < 1OO:l. 
After the third booster injections the titres were 
increased considerably and the blood samples 
obtained at this time were fully tested; the cross 
reactions and working dilutions being presented in 
table 1. The detection limit for 6/?-hydroxycortisol 
was 20 pg using antiserum Rl B2 (distinguishable 
from zero with 99% certainty). 
4. Discussion 
Steroid-specific antisera for radioimmunoassay can 
be prepared by linking the steroid to a carrier using 
existing functional groups of the steroid molecule. 
The specificity of the resulting antisera is high only 
when the accessible part of the steroid is structurally 
unique [9,10]. In particular, it has been shown that 
corticoid-specific antisera may be obtained using 
antigens in which the steroid is linked to the immuno- 
genic carrier through the 3 position [9] and so we 
elected to synthesise a 6fl-hydroxycortisol-3-BSA 
conjugate. 
6@Hydroxycortisol21 -acetate was prepared by 
photolytic autooxidation of the corresponding 3,5- 
dienol3-ethyl ether [ 1 l] . The selective formation of 
the 3(@carboxymethyl)oxime via an enamine [ 121 
was not possible in this case because of the presence 
of the 6fl-hydroxyl functicn, however we found that, 
in cold pyridine, the 21 -acetate provided sufficient 
protection of the 20-ketone to allow selective con- 
version of the 3-ketone. Inspection of the n.m.r. 
spectrum of the product confirmed the presence of 
the carboxymethylene group and indicated there to 
be a mixture of syn and anti isomers. The chemical 
shift and splitting pattern of the 6a-proton in the 
spectrum show that the stereochemistry of the 6/3- 
hydroxyl had not been disturbed. Previous reports 
have shown that there is no obvious advantage in 
removing the acetate groups prior to coupling a 
derivatised steroid to BSA [9,13] and the low cross- 
reactions for B&hydroxycortisol21 -acetate shown in 
table 1 confirm this. 
Three of the four antisera tested showed good 
discrimination against cortisol and were fully charac- 
terised. The best of these (Rl B2) showed good all- 
round specificity and should be of value in the mea- 
surement of 6fl-hydroxycortisol in urine, where the 
compounds that did give some cross-reaction are, at 
most, only present in relatively low concentrations. 
As the normal daily production of 6/Ghydroxycortisol 
is approximately 300 &day [ 141, it should be 
possible to measure this steroid in a fraction of a 
microlitre of urine. Thus it may be possible to assay 
unextracted urine, since such a tiny volume of urine 
is unlikely to interfere in an assay [ 151. 
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